215 related articles for article (PubMed ID: 9164792)
1. Medication for children with attention disorders.
Kash IJ
Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9164792
[No Abstract] [Full Text] [Related]
2. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
3. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
4. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
5. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
6. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
7. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
Mott TF; Leach L; Johnson L
J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
[No Abstract] [Full Text] [Related]
8. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
Le Heuzey MF; Vergnaud S; Mouren MC
Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
[TBL] [Abstract][Full Text] [Related]
9. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
10. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
Shalev R; Gross-Tsur V
Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
[No Abstract] [Full Text] [Related]
11. Flawed attention-deficit/hyperactivity disorder medication comparison.
Adesman A
Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
[No Abstract] [Full Text] [Related]
12. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
[TBL] [Abstract][Full Text] [Related]
13. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
[TBL] [Abstract][Full Text] [Related]
14. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
15. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
16. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
17. A new way to deliver psychiatric meds.
Levin-Epstein M
Behav Healthc; 2006 Aug; 26(8):22-3. PubMed ID: 16961036
[No Abstract] [Full Text] [Related]
18. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
Ghanizadeh A
Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459
[No Abstract] [Full Text] [Related]
19. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
Corkum P; Panton R; Ironside S; Macpherson M; Williams T
J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]